C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2009
12/10/2009	WO2009116982A3 Pre-or post-exposure treatment for filovirus or arenavirus infection
12/10/2009	WO2009114504A3 Reducing conjugative plasmids in bacteria
12/10/2009	US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090305898 Methods and Compositions for Identifying a Peptide Having an Intermolecular Interaction With a Target of Interest
12/10/2009	US20090305398 Recombinant Double-Stranded RNA Phage, and Use of the Same
12/10/2009	US20090305385 Novel Cultured Silkworm Cells Capable of Highly Efficient Baculovirus Production and Protein Production
12/10/2009	US20090305344 Chimeric alphavirus replicon particles
12/10/2009	US20090304799 Nanoemulsion influenza vaccine
12/10/2009	US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region
12/10/2009	US20090304738 Methods for Enhancing Immune Responses
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	DE19612966B4 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren MDCK cells and methods for the propagation of influenza virus
12/10/2009	CA2723999A1 Pestivirus replicons providing an rna-based viral vector system
12/09/2009	EP2130912A1 Pestivirus replicons providing an RNA-based viral vector system
12/09/2009	EP2129390A2 Turkey herpesvirus vectored recombinant containing avian influenza genes
12/09/2009	EP1040198B1 Recombinant rhabdovirus containing a heterologous fusion protein
12/09/2009	EP0912724B1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
12/09/2009	CN100566753C A hepatitis C virus codon optimized non-structural NS3/4A fusion gene
12/08/2009	US7629153 Methods and compositions relating to improved lentiviral vector production systems
12/08/2009	US7629138 Estrogen receptor genes and utilization thereof
12/08/2009	US7628980 Inducing long-term protection against foreign antigens and tumor antigens by administering a type I interferon or a FMS-like tyrosine kinase 3 (Flt-3), optionally along with an attenuated virus; increasing of the number of dendritic cells
12/08/2009	CA2558864C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
12/03/2009	WO2009146210A2 New human parvovirus: bocavirus
12/03/2009	WO2009144958A1 Recombinant virus, escherichia coli retaining the same and a process for production thereof
12/03/2009	WO2009144353A1 Attenuated vaccine for foot-and-mouth disease
12/03/2009	US20090298086 a polynucleotide comprising a nucleotide sequence or complement encoding a polypeptide comprising a farnesyltranstransferase beta subunit, used to improve tolerance to drought in mature plants
12/03/2009	US20090297561 Method for vaccination of poultry by bacteriophage lysate bacterin
12/03/2009	US20090297557 Human parvovirus: bocavirus
12/03/2009	US20090297555 Recombinant human cytomegalovirus and vaccines comprising heterologous antigens
12/03/2009	US20090297554 Multi Plasmid System For The Production Of Influenza Virus
12/02/2009	EP2128261A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof
12/02/2009	EP2128256A2 Molecular clones with mutated HIV GAG/POL, SIV GAG and SIV ENV genes
12/02/2009	CN101591658A ING4 and IL-24 dual gene co-expression vector and application thereof
12/02/2009	CN101591657A Thymosin beta4 gene expression inhibiting RNA and use thereof
12/02/2009	CN101591647A Viral particles with exogenous internal epitopes
12/02/2009	CN101591646A Dendritic cell vaccine for treating human cervical carcinoma
12/02/2009	CN100564521C Virus-like particles containing O-type foot-and-mouth disease virus IRES RNA, preparation method and application
12/02/2009	CN100564520C High throughput system for producing recombinant viruses using site-specific recombination
12/01/2009	US7625742 Avian leukosis viruses and polypeptide display
12/01/2009	US7625741 Used to control the growth of E. coli O157:H7; extracellular matrix (ECMl); to control or prevent the infection or colonization of processed and unprocessed food products
12/01/2009	US7625740 Having strong lytic activity; used control the growth of Clostridium perfringens; for controlling disease particularly those caused by antibiotic resistant organisms
12/01/2009	US7625739 Having strong lytic activity; used control the growth of Clostridium perfringens; for controlling disease particularly those caused by antibiotic resistant organisms
12/01/2009	US7625556 E. coli bacteriophage and uses thereof
12/01/2009	CA2430607C Self-replicating rna molecule from hepatitis c virus
12/01/2009	CA2298956C Genetically engineered cell culture adapted infectious bursal diseases virus (ibdv) mutants
11/2009
11/26/2009	WO2009082664A3 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof
11/26/2009	US20090291503 Recombinant Adeno-Associated Virus Production
11/26/2009	US20090291429 Substances causing differentiation
11/26/2009	US20090291428 Compositions and methods for the detection and treatment of poxviral infections
11/26/2009	US20090291063 Compositions and methods for the treatment of viral hepatitis
11/25/2009	EP2123755A1 Attenuated minus-stranded rna virus
11/25/2009	EP2121764A1 Viral polyhedra complexes and methods of use
11/25/2009	EP2121011A2 Vaccines including antigen from four strains of influenza virus
11/25/2009	EP1545594B1 Bacteriophage-mediated immunisation against hepatitis
11/25/2009	CN101586120A Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector
11/25/2009	CN101586096A Recombinant virus with coexpression of anthropogenic glutamate decarboxylase and cell factor
11/25/2009	CN100562570C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
11/24/2009	US7622293 Phenotypes; for the removal of antibiotic-resistant or other undesirable pathogens from medical, veterinary, and animal husbandry applications
11/24/2009	US7622123 A chimeric, infectious human-bovine chimeric parainfluenza virus (PIV) comprising a major nucleocapsid protein, a nucleocapsid phosphoprotein , a large polymerase protein, and a PIV background genome or antigenome of a human PIV3 combined with a M gene or genome segment of bovin PIV
11/24/2009	CA2303768C Methods and vector constructs useful for production of recombinant aav
11/19/2009	WO2009140326A2 Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids
11/19/2009	WO2009099716A4 Novel vaccines against multiple subtypes of dengue virus
11/19/2009	US20090288179 Inactivated Nodavirus Vaccine
11/19/2009	US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320
11/19/2009	US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009	US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/18/2009	EP1711518B1 Chimpanzee adenovirus vaccine carriers
11/18/2009	EP1385968B1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/18/2009	EP0914422B1 Mammalian genes involved in viral infection
11/18/2009	EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009	CN101580849A Dna-transfection system for generation of infectious influenza virus
11/18/2009	CN101580833A SiRNA for inhibiting rat Atpase a3 gene expression, recombinant slow virus and application in medicament for treating bone absorption abnormal diseases
11/18/2009	CN100560719C MELAN-A peptide analogue-virus-like-particle conjugates
11/17/2009	US7619060 Cytoplasmic polyhedrosis virus protein complex of a polyhedrin and a VP3 polypeptide
11/17/2009	US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009	US7618802 Compositions of coronaviruses with a recombination-resistant genome
11/17/2009	US7618623 Hybrid adeno-retroviral vector for the transfection of cells
11/12/2009	WO2009136977A2 Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof
11/12/2009	WO2009136382A2 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
11/12/2009	WO2009135936A1 Method for concentrating and isolating biomolecules or viruses
11/12/2009	WO2009135518A1 Chimeric fusion proteins and virus like particles from birnavirus vp2
11/12/2009	WO2009135295A1 Phage lambda display constructs
11/12/2009	US20090281041 Antiviral cell-penetrating peptides
11/12/2009	US20090280552 novel adenovirus that can kills mammalian cancer cells efficiently by producing a novel protein that converts two non-toxic prodrugs into potent chemotherapeutic agents
11/12/2009	US20090280533 Serum-free mammalian cell culture medium, and uses thereof
11/12/2009	US20090280532 Serum-free mammalian cell culture medium, and uses thereof
11/12/2009	US20090280473 Inhibition of membrane fusion proteins
11/12/2009	US20090280144 Recombinant newcastle disease virus RNA expression systems and vaccines
11/12/2009	DE102008023297A1 Verfahren zur Anreicherung und Isolierung von Biomolekühlen oder Viren Method for the enrichment and isolation of viruses or Biomolekühlen
11/12/2009	CA2761105A1 Phage lambda display constructs
11/12/2009	CA2716928A1 Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof
11/11/2009	EP2114459A1 Recombinant viral vectors for prevention and protection against alphavirus infection
11/11/2009	EP2114449A1 Herpes simplex virus combined subunit vaccines and methods of use thereof
11/11/2009	EP1654390B1 Liquid crystal based analyte detection
11/11/2009	EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
11/11/2009	EP1278874B1 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/11/2009	CN101578362A Influencing viral lipid constituents
11/11/2009	CN101575593A Vaccine for hand-foot-mouth disease and preparation method and application thereof
11/11/2009	CN101575592A Virulent phage sensitive to riemerella anatipestifer and application thereof

1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 267